Ali Hariri

Company: Eloxx Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Protein Restoration Therapy: Circumventing the Genetic Defect in Alport Syndrome & PKD 2:00 pm

Delving into the challenges and opportunities of carrying out a protein restoration therapy for rare kidney diseases  Is a kidney biopsy sufficient proof of efficacy? Using registry studies to achieve rapid approval to be converted into full-approvalRead more

day: Conference Day One Track B PM